At Tuesday’s closing price, Mankind Pharma was valued at a price-to-earnings ratio of 43 times its FY22 earnings. Mankind is now India’s fifth largest pharma company by market value of ₹57,046 crore. Sun Pharma, Divi’s Lab, Dr. Reddy’s Lab, and Cipla are currently valued between ₹75,284 crore and ₹2.31 lakh crore.
Concurrent Gainers: 7 stocks that gained for 5 days in a row
In the five trading sessions prior to March 7, the Sensex rose by around 1.5%, or 1,134 points, closing at 74,333. The market ended on
March 8, 2025